je.st
news
Novo Nordisk to end German sales of new insulin drug after price row
2015-07-01 20:23:39| Biotech - Topix.net
COPENHAGEN: Denmark's Novo Nordisk, the world's biggest insulin producer, is to stop selling its new long-acting insulin drug Tresiba in Germany following a row over pricing. The decision is the latest example of tensions between drugmakers and healthcare providers, many of whom are unhappy about the high cost of modern medicines.
Tags: price
end
sales
german
Category:Biotechnology and Pharmaceuticals